1. Epirubicin dose and sequential hormonal therapy—Mature results of the HMFEC randomised phase III trial in premenopausal patients with node positive early breast cancer. (June 2016) Authors: Coombes, R.C.; Kilburn, L.S.; Tubiana-Mathieu, N.; Olmos, T.; Van Bochove, A.; Perez-Lopez, F.R.; Palmieri, C.; Stebbing, J.; Bliss, J.M. Journal: European journal of cancer Issue: Volume 60(2016) Page Start: 146 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗